unknown by Ad, Niv et al.
2 8 6 Letters to the Editor 
The Journal of Thoracic and 
Cardiovascular Surgery 
January 1996 
I am delighted to call attention to a scientific ontribu- 
tion made 25 years ago. 
Ricardo M. Leyro-Diaz, MD 
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Uspallata 3400 
1437, Buenos Aires, Argentina 
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Reply to the Editor." 
We thank Dr. Leyro-Diaz for bringing to our attention 
the report by Drs. Luluaga and Yosifides de Luluaga on 
their clinical experience. Their work, in which they used a 
device closely resembling ours, is very important. Such an 
experience with two patients with an atrial septal defect 
and pulmonary hypertension contributes greatly to the 
establishment of this surgical concept of decompressing 
the right ventricle through an interatrial communication 
to reduce the risk of postoperative right heart failure. We 
congratulate Drs. Luinaga and Yosifides de Luluaga for 
this early work. We wish their work had been published in 
the English medical literature, so that it would have been 
available to English-speaking physicians. 
A prospective clinical trial comprising 15 patients has 
already been performed and will be published in Trm 
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. In 
this trial, patients for whom the one-way, valved, atrial septal 
patch was deemed suitable were divided into three groups: 
group 1 comprised patients with hypoplastic right ventricle, 
small tricuspid valve, and severe pulmonic stenosis or atresia; 
group 2 comprised patients with high pulmonary vascular 
resistance resulting from a large left-to-right shunt from an 
atrial or ventricular septal defect; and group 3 comprised 
patients with intraoperative acute right heart failure devel- 
oping after complete repair of their congenital malforma- 
tion. The right heart failure was resistant to maximal phar- 
macologic treatment, and the device was used as a last resort 
to wean the patients from cardiopulmonary b pass. 
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Monofilament polypropylene sutures in aortic 
valve replacement 
To the Editor." 
We read with interest a recent article from Gott and 
associates ~ reporting extremely low rates of thromboem- 
bolism after aortic root replacement. The authors pec- 
ulated in their discussion section that the lower inci- 
dence of thromboembolism may h ve been related to 
the fact that the valve sutures, pledgets, knots, and 
much of the valve sewing ring are excluded from the 
bloodstream in a composite graft but remain exposed in 
isolated valve replacement. We agree with this state- 
ment and believe that suture material may increase the 
likelihood of morbid complications such as thromboem- 
bolism and prosthetic valve endocarditis (PVE) after 
cardiac operations. Despite major advances, such as the 
development of antimicrobial prophylaxis, better pre- 
operative preparation of the skin, improved surgical 
techniques, early, aggressive treatment of wound infec- 
tion, and prevention of low-output syndrome after 
operation, PVE continues to complicate the course of 
2% to 4% of patients after cardiac valve replacement. 2 
We report here our experiences related to PVE after 
aortic valve replacement (AVR). 
In the early phase of cardiac surgery at our hospital, 
polyfilament suture material was used in AVR. We ana- 
lyzed the cases of a series of 283 patients operated on 
from 1972 to 1984, In this series, all prostheses basically 
had interrupted single sutures without pledgets. Eleven of 
the patients (4.1%) had infective PVE or periprosthetic 
leakage and had to undergo reoperation. At reoperation, 
swelling and untying of the polyfilament sutures and 
penetration of infection deeply into the aortic wall along 
the sutures, causing annular abscesses, were encountered. 
This experience l d us to change the suture material, and 
since the mid-1980s we have routinely used 2-0 Prolene 
sutures (Ethicon, Inc., Somerville, N.J.) in all AVRs, 
inserting 30 to 40 interrupted single sutures without 
pledgets. We have now evaluated our 583 AVR opera- 
tions from 1985 to 1994, and to date only one patient with 
infective PVE and periprosthetic leakage has needed 
reoperation, a rate of 0.1%. 
The suture material used in cardiac valve replacements 
in general varies between monofilament and multifila- 
ment types. In a study on the effect of suture material 
on the development of vascular infection, 102 Staphylo- 
coccus aureus bacteria were injected intravenously after 
aortotomy closure with various materials. 3 The study 
indicated that monofilament, nonabsorbable sutures 
were less likely to be associated with suture line infec- 
tion. Polyfilament material was found to have a dis- 
tinctly increased bacterial affinity relative to monofila- 
ment. 4 Our experience supports this finding. We 
conclude that single interrupted 2-0 Prolene sutures are 
a safe choice for AVR. 
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